methylprednisolone has been researched along with darunavir in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 5 (71.43) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cattaneo, D; Cheli, S; Clementi, E; Fusi, M; Gervasoni, C | 1 |
BagalĂ , A; Bartiromo, M; Bartoloni, A; Borchi, B; Botta, A; Bresci, S; Cavallo, A; Cirami, C; CutruzzulĂ , R; Larti, A; Lugli, G; Tilli, M; Vaglio, A; Xhaferi, B | 1 |
Anselmi, E; Cavanna, L; Citterio, C; Codeluppi, M; Stroppa, EM; Toscani, I; Zaffignani, E | 1 |
Chen, C; Chen, M; Cheng, C; Chi, Y; Hu, Z; Huang, S; Jiao, D; Liang, C; Liu, Y; Lv, Y; Sun, W; Wei, H; Yi, Y; Zhang, X | 1 |
Alessandrini, AI; Baldi, F; Balletto, E; Barisione, E; Bassetti, M; Beltramini, S; Berruti, M; Briano, F; Bruzzone, B; Camera, M; Da Rin, G; De Maria, A; Delfino, E; Dentone, C; Dettori, S; Di Biagio, A; Dodi, F; Ferrazin, A; Giacobbe, DR; Giacomini, M; Gratarola, A; Icardi, G; Labate, L; Magnasco, L; Mazzarello, G; Mikulska, M; Mirabella, M; Mora, S; Nicolini, LA; Orsi, A; Pelosi, P; Pincino, R; Portunato, F; Rosseti, N; Russo, C; Sasso, E; Schenone, E; Sepulcri, C; Signori, A; Sormani, MP; Taramasso, L; Toscanini, F; Tutino, S; Vena, A | 1 |
Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J | 1 |
1 review(s) available for methylprednisolone and darunavir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for methylprednisolone and darunavir
Article | Year |
---|---|
Different effects of glucocorticoids on darunavir plasma concentrations.
Topics: Cytochrome P-450 CYP3A; Darunavir; Drug Combinations; Drug Interactions; Glucocorticoids; HIV Infections; HIV Protease Inhibitors; Humans; Intervertebral Disc Displacement; Male; Methylprednisolone; Middle Aged; Prednisone; Trigeminal Neuralgia | 2019 |
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
Topics: Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Ciliopathies; Cobicistat; Common Cold; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deprescriptions; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Fatigue; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; Interleukin-10; Interleukin-1beta; Interleukin-6; Interleukin-8; Kidney Diseases, Cystic; Kidney Failure, Chronic; Kidney Transplantation; Leber Congenital Amaurosis; Lopinavir; Methylprednisolone; Optic Atrophies, Hereditary; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Topics: Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Methylprednisolone; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
Topics: Adolescent; Adult; Antiviral Agents; Betacoronavirus; China; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Female; Humans; Indoles; Male; Methylprednisolone; Olfaction Disorders; Pandemics; Pneumonia, Viral; SARS-CoV-2; Taste Disorders; Treatment Outcome; Vitamin B 12 | 2020 |
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Female; Follow-Up Studies; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |